8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Eli Lilly ($LLY) furnished a press release on Feb 4, 2026 announcing financial results for the quarter and…
Filed with the SEC on · Summarized by InvestorsBot
Eli Lilly ($LLY) furnished a press release on Feb 4, 2026 announcing financial results for the quarter and year ended Dec 31, 2025. Investors should review the release for revenue, EPS and guidance updates. 📢📅 #Earnings #Pharma
The Item 2.02 disclosure is furnished — not “filed” — meaning it’s not subject to Section 18 liability and won’t be automatically incorporated by reference into SEC registration statements. ⚖️ $LLY #SEC #Investing
The press release is attached as Exhibit 99.1 to the 8‑K (Feb 4, 2026). Check Exhibit 99.1 for full FY2025 & Q4 results, management commentary and any guidance changes. 🔎 $LLY #EarningsRelease #LLY